Recently, pieces of evidence have demonstrated that the TGF-β signaling pathway can also interact with the Wnt/β-catenin signaling pathway, which contributes to tumor progression and invasion by sequentially activating the downstream effectors of TCF/LEF transcription factors (21, 23, 24). This evidence concerns the gene TGFB1 and neoplasm.